Influence of 5-HTTLPR polymorphism on resting state perfusion in patients with major depression

Journal of Psychiatric Research

Volumn 45, Issue 4, 2011, Pages 442-451

  Brockmann, Holger ^a,b   Zobel, Astrid ^a   Schuhmacher, Anna ^a   Daamen, Marcel ^a   Joe, Alexius ^a   Biermann, Kim ^a   Schwab, Sibylle G ^a,c,d   Biersack, Hans Juergen ^a   Maier, Wolfgang ^a   Boecker, Henning ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

5 HTTLPR; Depression; Genetics; HMPAO SPECT

Indexed keywords

ADULT; ALLELE; AMYGDALOID NUCLEUS; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DNA POLYMORPHISM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL PATIENT; POST HOC ANALYSIS; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; TREATMENT RESPONSE;

ADULT; ANALYSIS OF VARIANCE; BRAIN; BRAIN MAPPING; DEPRESSIVE DISORDER, MAJOR; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PSYCHIATRIC STATUS RATING SCALES; RADIOPHARMACEUTICALS; REST; RETROSPECTIVE STUDIES; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TECHNETIUM TC 99M EXAMETAZIME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 79952629144     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2010.08.016     Document Type: Article

References (71)

1. Abercrombie H.C., Schaefer S.M., Larson C.L., Oakes T.R., Lindgren K.A., Holden J.E., et al. Metabolic rate in the right amygdala predicts negative affect in depressed patients. Neuroreport 1998, 9:3301-3307.
2. Acton P.D., Friston K.J. Statistical parametric mapping in functional neuroimaging: beyond PET and fMRI activation studies. European Journal of Nuclear Medicine 1998, 25:663-667.
3. Amaral D.G., Price J.L. Amygdalo-cortical projections in the monkey (Macaca fascicularis). The Journal of Comparative Neurology 1984, 230:465-496.
4. Anand A., Li Y., Wang Y., Wu J., Gao S., Bukhari L., et al. Activity and connectivity of brain mood regulating circuit in depression: a functional magnetic resonance study. Biological Psychiatry 2005, 57:1079-1088.
5. Baxter L.R., Schwartz J.M., Phelps M.E., Mazziotta J.C., Guze B.H., Selin C.E., et al. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Archives of General Psychiatry 1989, 46:243-250.
6. Bertolino A., Arciero G., Rubino V., Latorre V., De Candia M., Mazzola V., et al. Variation of human amygdala response during threatening stimuli as a function of 5'HTTLPR genotype and personality style. Biol Psychiatry 2005, 57:1517-1525.
7. Blier P., de Montigny C. Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders. Neuropsychopharmacology 1999, 21:91S-98S.
8. Botteron K.N., Raichle M.E., Drevets W.C., Heath A.C., Todd R.D. Volumetric reduction in left subgenual prefrontal cortex in early onset depression. Biological Psychiatry 2002, 51:342-344.
9. Brockmann H., Zobel A., Joe A., Biermann K., Scheef L., Schuhmacher A., et al. The value of HMPAO SPECT in predicting treatment-response to citalopram in patients with major depression. Psychiatry Research: Neuroimaging 2009, 173:107-112.
10. Canli T., Qiu M., Omura K., Congdon E., Haas B.W., Amin Z., et al. Neural correlates of epigenesis. Proceedings of the National Academy of Sciences USA 2006, 103:16033-16038.
11. Cervilla J.A., Molina E., Rivera M., Torres-Gonzalez F., Bellon J.A., Moreno B., et al. The risk for depression conferred by stressful life events is modified by variation at the serotonin transporter 5HTTLPR genotype: evidence from the Spanish PREDICT-Gene cohort. Molecular Psychiatry 2007, 12:748-755.
12. Chen C.H., Suckling J., Ooi C., Fu C.H., Williams S.C., Walsh N.D., et al. Functional coupling of the amygdala in depressed patients treated with antidepressant medication. Neuropsychopharmacology 2008, 33:1909-1918.
13. Dannlowski U., Ohrmann P., Bauer J., Deckert J., Hohoff C., Kugel H., et al. 5-HTTLPR biases amygdala activity in response to masked facial expressions in major depression. Neuropsychopharmacology 2008, 33:418-424.
14. Deutsche Gesellschaft für Psychiatrie P.u.N. Behandlungsleitlinie Affektive Erkrankungen 2000, Steinkopff Verlag, Darmstadt, Germany.
15. Drevets W.C. Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression. Progress in Brain Research 2000, 126:413-431.
16. Drevets W.C. Neuroimaging studies of mood disorders. Biological Psychiatry 2000, 48:813-829.
17. Drevets W.C., Bogers W., Raichle M.E. Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism. European Neuropsychopharmacology 2002, 12:527-544.
18. Drevets W.C., Price J.L., Furey M.L. Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Structure and Function 2008, 213:93-118.
19. Drevets W.C., Thase M.E., Moses-Kolko E.L., Price J., Frank E., Kupfer D.J., Mathis C. Serotonin-1A receptor imaging in recurrent depression: replication and literature review. Nuclear Medicine and Biology 2007, 34:865-877.
20. Drevets W.C., Videen T.O., Price J.L., Preskorn S.H., Carmichael S.T., Raichle M.E. A functional anatomical study of unipolar depression. The Journal of Neuroscience 1992, 12:3628-3641.
21. Friedel E., Schlagenhauf F., Sterzer P., Park S.Q., Bermpohl F., Strohle A., et al. 5-HTT genotype effect on prefrontal-amygdala coupling differs between major depression and controls. Psychopharmacology (Berl) 2009, 205:261-271.
22. Greicius M.D., Flores B.H., Menon V., Glover G.H., Solvason H.B., Kenna H., et al. Resting-state functional connectivity in major depression: abnormally increased contributions from subgenual cingulate cortex and thalamus. Biological Psychiatry 2007, 62:429-437.
23. Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry 1960, 23:56-62.
24. Hariri A.R., Drabant E.M., Munoz K.E., Kolachana B.S., Mattay V.S., Egan M.F., Weinberger D.R. A susceptibility gene for affective disorders and the response of the human amygdala. Archives of General Psychiatry 2005, 62:146-152.
25. Hariri A.R., Holmes A. Genetics of emotional regulation: the role of the serotonin transporter in neural function. Trends in Cognitive Sciences 2006, 10:182-191.
26. Hasler G., Fromm S., Carlson P.J., Luckenbaugh D.A., Waldeck T., Geraci M., et al. Neural response to catecholamine depletion in unmedicated subjects with major depressive disorder in remission and healthy subjects. Archives of General Psychiatry 2008, 65:521-531.
27. Hauser J., Leszczynska A., Samochowiec J., Czerski P.M., Ostapowicz A., Chlopocka M., et al. Association analysis of the insertion/deletion polymorphism in serotonin transporter gene in patients with affective disorder. European Psychiatry 2003, 18:129-132.
28. Heils A., Teufel A., Petri S., Stober G., Riederer P., Bengel D., Lesch K.P. Allelic variation of human serotonin transporter gene expression. Journal of Neurochemistry 1996, 66:2621-2624.
29. Heinz A., Braus D.F., Smolka M.N., Wrase J., Puls I., Hermann D., et al. Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter. Nature Neuroscience 2005, 8:20-21.
30. Heinz A., Smolka M.N., Braus D.F., Wrase J., Beck A., Flor H., et al. Serotonin transporter genotype (5-HTTLPR): effects of neutral and undefined conditions on amygdala activation. Biological Psychiatry 2007, 61:1011-1014.
31. Hirschfeld R.M., Montgomery S.A., Aguglia E., Amore M., Delgado P.L., Gastpar M., et al. Partial response and nonresponse to antidepressant therapy: current approaches and treatment options. Journal of Clinical Psychiatry 2002, 63:826-837.
32. Hoefgen B., Schulze T.G., Ohlraun S., von Widdern O., Hofels S., Gross M., et al. The power of sample size and homogenous sampling: association between the 5-HTTLPR serotonin transporter polymorphism and major depressive disorder. Biological Psychiatry 2005, 57:247-251.
33. Hu X.Z., Lipsky R.H., Zhu G., Akhtar L.A., Taubman J., Greenberg B.D., et al. Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. The American Journal of Human Genetics 2006, 78:815-826.
34. Kim I.J., Kim S.J., Kim Y.K. Age- and sex-associated changes in cerebral glucose metabolism in normal healthy subjects: statistical parametric mapping analysis of F-18 fluorodeoxyglucose brain positron emission tomography. Acta Radiologica 2009, 50:1169-1174.
35. Kiyohara C., Yoshimasu K. Association between major depressive disorder and a functional polymorphism of the 5-hydroxytryptamine (serotonin) transporter gene: a meta-analysis. Psychiatric Genetics 2009.
36. Lancaster J.L., Woldorff M.G., Parsons L.M., Liotti M., Freitas C.S., Rainey L., et al. Automated Talairach atlas labels for functional brain mapping. Human Brain Mapping 2000, 10:120-131.
37. Lasky-Su J.A., Faraone S.V., Glatt S.J., Tsuang M.T. Meta-analysis of the association between two polymorphisms in the serotonin transporter gene and affective disorders. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2005, 133B:110-115.
38. Lesch K.P., Bengel D., Heils A., Sabol S.Z., Greenberg B.D., Petri S., et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996, 274:1527-1531.
39. Lotrich F.E., Pollock B.G. Meta-analysis of serotonin transporter polymorphisms and affective disorders. Psychiatric Genetics 2004, 14:121-129.
40. Lucki I. The spectrum of behaviors influenced by serotonin. Biological Psychiatry 1998, 44:151-162.
41. Ma N., Li L., Shu N., Liu J., Gong G., He Z., et al. White matter abnormalities in first-episode, treatment-naive young adults with major depressive disorder. The American Journal of Psychiatry 2007, 164:823-826.
42. Maldjian J.A., Laurienti P.J., Burdette J.H. Precentral gyrus discrepancy in electronic versions of the Talairach atlas. Neuroimage 2004, 21:450-455.
43. Maldjian J.A., Laurienti P.J., Kraft R.A., Burdette J.H. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage 2003, 19:1233-1239.
44. Mayberg H.S. Frontal lobe dysfunction in secondary depression. The Journal of Neuropsychiatry and Clinical Neurosciences 1994, 6:428-442.
45. Mayberg H.S. Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. British Medical Bulletin 2003, 65:193-207.
46. Mayberg H.S., Liotti M., Brannan S.K., McGinnis S., Mahurin R.K., Jerabek P.A., et al. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. The American Journal of Psychiatry 1999, 156:675-682.
47. Mendlewicz J., Massat I., Souery D., Del-Favero J., Oruc L., Nothen M.M., et al. Serotonin transporter 5HTTLPR polymorphism and affective disorders: no evidence of association in a large European multicenter study. European Journal of Human Genetics 2004, 12:377-382.
48. Munafo M.R., Brown S.M., Hariri A.R. Serotonin transporter (5-HTTLPR) genotype and amygdala activation: a meta-analysis. Biological Psychiatry 2008, 63:852-857.
49. Nakamura M., Ueno S., Sano A., Tanabe H. The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants. Molecular Psychiatry 2000, 5:32-38.
50. Neumeister A., Drevets W.C., Belfer I., Luckenbaugh D.A., Henry S., Bonne O., et al. Effects of a alpha 2C-adrenoreceptor gene polymorphism on neural responses to facial expressions in depression. Neuropsychopharmacology 2006, 31:1750-1756.
51. Neumeister A., Hu X.Z., Luckenbaugh D.A., Schwarz M., Nugent A.C., Bonne O., et al. Differential effects of 5-HTTLPR genotypes on the behavioral and neural responses to tryptophan depletion in patients with major depression and controls. Archives of General Psychiatry 2006, 63:978-986.
52. Neumeister A., Nugent A.C., Waldeck T., Geraci M., Schwarz M., Bonne O., et al. Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controls. Archives of General Psychiatry 2004, 61:765-773.
53. Parsey R.V., Hastings R.S., Oquendo M.A., Hu X., Goldman D., Huang Y.Y., et al. Effect of a triallelic functional polymorphism of the serotonin-transporter-linked promoter region on expression of serotonin transporter in the human brain. The American Journal of Psychiatry 2006, 163:48-51.
54. Pezawas L., Meyer-Lindenberg A., Drabant E.M., Verchinski B.A., Munoz K.E., Kolachana B.S., et al. 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nature Neuroscience 2005, 8:828-834.
55. Praschak-Rieder N., Kennedy J., Wilson A.A., Hussey D., Boovariwala A., Willeit M., et al. Novel 5-HTTLPR allele associates with higher serotonin transporter binding in putamen: a [(11)C] DASB positron emission tomography study. Biological Psychiatry 2007, 62:327-331.
56. Rao H., Gillihan S.J., Wang J., Korczykowski M., Sankoorikal G.M., Kaercher K.A., et al. Genetic variation in serotonin transporter alters resting brain function in healthy individuals. Biological Psychiatry 2007, 62:600-606.
57. Ressler K.J., Mayberg H.S. Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic. Nature Neuroscience 2007, 10:1116-1124.
58. Risch N., Herrell R., Lehner T., Liang K.Y., Eaves L., Hoh J., et al. Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis. The Journal of the American Medical Association 2009, 301:2462-2471.
59. Rosenkranz J.A., Moore H., Grace A.A. The prefrontal cortex regulates lateral amygdala neuronal plasticity and responses to previously conditioned stimuli. The Journal of Neuroscience 2003, 23:11054-11064.
60. Savitz J.B., Drevets W.C. Imaging phenotypes of major depressive disorder: genetic correlates. Neuroscience 2009, 164:300-330.
61. Schinka J.A., Busch R.M., Robichaux-Keene N. A meta-analysis of the association between the serotonin transporter gene polymorphism (5-HTTLPR) and trait anxiety. Molecular Psychiatry 2004, 9:197-202.
62. Serretti A., Kato M., De Ronchi D., Kinoshita T. Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients. Molecular Psychiatry 2007, 12:247-257.
63. Sheline Y.I. Hippocampal atrophy in major depression: a result of depression-induced neurotoxicity?. Molecular Psychiatry 1996, 1:298-299.
64. Sheline Y.I., Barch D.M., Donnelly J.M., Ollinger J.M., Snyder A.Z., Mintun M.A. Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study. Biological Psychiatry 2001, 50:651-658.
65. Sheline Y.I., Gado M.H., Kraemer H.C. Untreated depression and hippocampal volume loss. The American Journal of Psychiatry 2003, 160:1516-1518.
66. Tatsch K., Asenbaum S., Bartenstein P., Catafau A., Halldin C., Pilowsky L.S., Pupi A. European association of nuclear medicine procedure guidelines for brain perfusion SPET using (99 m)Tc-labelled radiopharmaceuticals. European Journal of Nuclear Medicine and Molecular Imaging 2002, 29:BP36-BP42.
67. Taylor W.D., Steffens D.C., Payne M.E., MacFall J.R., Marchuk D.A., Svenson I.K., Krishnan K.R. Influence of serotonin transporter promoter region polymorphisms on hippocampal volumes in late-life depression. Archives of General Psychiatry 2005, 62:537-544.
68. Viviani R., Sim E.J., Lo H., Beschoner P., Osterfeld N., Maier C., et al. Baseline brain perfusion and the serotonin transporter promoter polymorphism. Biological Psychiatry 2010, 67:317-322.
69. Wendland J.R., Martin B.J., Kruse M.R., Lesch K.P., Murphy D.L. Simultaneous genotyping of four functional loci of human SLC6A4, with a reappraisal of 5-HTTLPR and rs25531. Molecular Psychiatry 2006, 11:224-226.
70. Wittchen H.U., Zaudig M., Fydrich T. Strukturiertesklinisches Interview für DSM-IV (SKID-I und SKID-II). Achse I psychische Störungen/Achse II Persönlichkeitsstörungen 1997, Hogrefe, Göttingen, Bern, Toronto, Seattle.
71. Worsley K.J., Neelin P., Vandal A.C., Friston K.J., Evans A.C. A unified statistical approach for determining significant signals in images of cerebral activation. Human Brain Mapping 1996, 4:58-73.